Eiger BioPharmaceuticals' Reverse Merger Round

Eiger BioPharmaceuticals raised a round of funding on November 19, 2015. Investors include Celladon.

Eiger is a biopharmaceutical company focused on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. Eiger's pipeline includes preclinical NCEs fr…

Articles about Eiger BioPharmaceuticals' Reverse Merger Round: